PYRAZOLO[4,3-B]PYRIDINE-7-AMINE INHIBITORS OF ALK5
    2.
    发明申请
    PYRAZOLO[4,3-B]PYRIDINE-7-AMINE INHIBITORS OF ALK5 有权
    吡嗪[4,3-B]吡啶-7-胺抑制剂ALK5

    公开(公告)号:US20130324528A1

    公开(公告)日:2013-12-05

    申请号:US13697421

    申请日:2011-05-10

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: The present invention provides ALK5 inhibitors of the formula wherein the variables are as defined herein. Also provided are pharmaceutical compositions, methods of making the compounds and intermediates thereof; and methods of using the compounds.

    摘要翻译: 本发明提供了下式的ALK5抑制剂,其中变量如本文所定义。 还提供了药物组合物,制备化合物及其中间体的方法; 和使用该化合物的方法。

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK
    3.
    发明授权
    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK 有权
    二氢吡咯并吡啶酮化合物作为JAK的抑制剂

    公开(公告)号:US08420816B2

    公开(公告)日:2013-04-16

    申请号:US12796583

    申请日:2010-06-08

    IPC分类号: C07D471/12

    摘要: Disclosed are JAK inhibitors of formula I where G1, R1, R2, R3, R4, R5, R6, and R7 are defined in the specification. Also disclosed are pharmaceutical compositions, kits and articles of manufacture which contain the compounds, methods and materials for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions involving the immune system and inflammation, including rheumatoid arthritis, hematological malignancies, epithelial cancers (i.e., carcinomas), and other diseases, disorders or conditions associated with JAK.

    摘要翻译: 公开了式I中的JAK抑制剂,其中在说明书中定义了G1,R1,R2,R3,R4,R5,R6和R7。 还公开了含有化合物的化合物,制备该化合物的方法和材料的药物组合物,试剂盒和制品,以及使用该化合物治疗涉及免疫系统和炎症的疾病,病症和病症的方法,包括类风湿性关节炎,血液学 恶性肿瘤,上皮癌(即癌)以及与JAK有关的其他疾病,病症或病症。